ロード中...
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
Circulating tumor DNA (ctDNA) has shown great promise as a minimally invasive liquid biopsy for personalized cancer diagnostics especially among metastatic patients. Here, we used a novel sensitive assay to detect clinically relevant mutations in ctDNA in blood plasma from metastatic non-small cell...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690267/ https://ncbi.nlm.nih.gov/pubmed/33105541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9112337 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|